A phase 3 randomized, multicenter, multinational, double

Project: Research project

Project Details

Description

A phase 3 randomized, multicenter, multinational, double-blinded study comparing the efficacy and safety of repeated biweekly infusions of neoGAA (GZ402666) and alglucosidase alfa in treatment naive patients with late onset Pompe disease
StatusActive
Effective start/end date6/14/176/29/20

Funding

  • GENZYME CORPORATION

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.